[PDF][PDF] Almanaques ou a sabedoria e as tarefas do tempo

MV Guerreiro, JDP Correia - Revista do Instituto de Cultura e …, 1986 - cvc.instituto-camoes.pt
A divisão do ano em função dos fenómenos nele observáveis e respectivo registo, o que,
em suma, constitui a parte nuclear do que chamamos almanaque, recua a épocas …

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

…, L Lopez Corral, JM Sanchez, M Guerreiro… - Cancer …, 2021 - Wiley Online Library
Tisagenlecleucel (tisa‐cel) is a second‐generation autologous CD19‐targeted chimeric
antigen receptor (CAR) T‐cell therapy approved for relapsed/refractory (R/R) large B‐cell …

[HTML][HTML] Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

…, RH Morales, V Ortiz-Maldonado, M Guerreiro… - …, 2023 - ncbi.nlm.nih.gov
Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are CD19-targeted chimeric
antigen receptor (CAR) T cells approved for relapsed/refractory (R/R) large B-cell …

Adiponectin is a negative regulator of antigen‐activated T cells

…, A Jenke, M Rother, M Guerreiro… - European journal of …, 2011 - Wiley Online Library
Adiponectin (APN), a cytokine constitutively produced in fat tissue, has been shown to exert
anti‐inflammatory effects in various disease models. While the influence of APN on …

SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: prospective survey from the Spanish …

…, C Solano, B Ferrer‐Lores, M Guerreiro… - American Journal of …, 2022 - Wiley Online Library
This is a multicenter prospective observational study that included a large cohort (n = 397)
of allogeneic (allo‐HSCT; (n = 311) and autologous (ASCT) hematopoietic stem cell …

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

…, A Roldán-Pérez, B Ferrer, M Guerreiro… - Blood cancer …, 2023 - nature.com
The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in
immunosuppressed patients such as hematological patients has been little explored. A …

[HTML][HTML] Prospective randomized study comparing myeloablative unrelated umbilical cord blood transplantation versus HLA-haploidentical related stem cell …

…, A Balaguer-Roselló, M Guerreiro… - Biology of Blood and …, 2020 - Elsevier
In this prospective randomized study, we compared the outcomes of single-unit umbilical cord
blood transplantation (UCBT) and unmanipulated haploidentical stem cell transplantation (…

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

…, F Giglio, A Facal, F Lorentino, M Guerreiro… - Bone Marrow …, 2022 - nature.com
Post-transplant cyclophosphamide (PTCy) has emerged as a promising graft-versus-host
disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplantation (allo-HSCT). …

Human peripheral blood and bone marrow Epstein–Barr virus‐specific T‐cell repertoire in latent infection reveals distinct memory T‐cell subsets

M Guerreiro, IK Na, A Letsch, D Haase… - European journal of …, 2010 - Wiley Online Library
EBV infection leads to life‐long viral persistence. Although EBV infection can result in chronic
disease and malignant transformation, most carriers remain disease‐free as a result of …

Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell …

…, R Hernani, I Lorenzo, A Pérez, M Guerreiro… - Bone Marrow …, 2020 - nature.com
Following the success of posttransplant cyclophosphamide (PT-CY) as graft-versus-host
disease (GVHD) prophylaxis in haploidentical transplantation, this prevention strategy has …